Registry of patients with chronic heart failure in Russia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry collects both retrospective and prospective data from patients diagnosed with chronic heart failure (CHF) across various regions of the Russian Federation. The study aims to gather comprehensive information on CHF patients without intervening in their treatment methods. Data will be collected from outpatient and inpatient settings until the end of 2027, allowing for a thorough analysis of CHF progression and management. The registry will include patients of any stage and functional class of CHF, providing valuable insights into the condition.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Any stage and/or any class of CHF

Exclusion Criteria:

* Subjects whose source records cant be obtained for the analysis

Where it's running

• National Medical Research Center for Cardiology, Ministry of Health of Russian Federation Organization
  Moscow, Russia Recruiting

Study contacts

• Principal investigator: Fail' T Ageev, Prof. — E.I.Chazov Cardiology Center
• Study coordinator: Olga N Svirida, MD, PhD
• Email: ONSvirida@Cardio.ru
• Phone: +74954146552

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Voice-based detection of heart failure deterioration using Noah Labs Vox

  This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.

  Recruiting Noah Labs · Boston, Massachusetts · NCT07870395

• Mobile-based telemedicine to improve quality of life for chronic heart failure patients

  We’re testing whether a mobile phone–based program that sends reminders, education, and follow-up can improve quality of life for adults with chronic heart failure in Ethiopia.

  Recruiting Select College · Addis Ababa · NCT07650474

• Restoring gut bacteria in adults with chronic heart failure

  This trial tests whether replacing gut bacteria with healthy donor bacteria (intestinal microbiota transplantation) can reduce inflammation and improve function in adults with chronic heart failure.

  Recruiting Phase 1 Columbia University · New York, New York · NCT07490054

• Biventricular or left bundle branch pacing to improve heart pumping after TAVI

  This research will try whether implanting a cardiac resynchronization device (biventricular or left bundle branch pacing) shortly after TAVI helps people who develop a persistent left bundle branch block and have mildly reduced heart function (EF 35%–55%).

  Recruiting Semmelweis University Heart and Vascular Center · Budapest · NCT07434193

• Vericiguat for right‑ventricular function and heart remodeling in HFrEF

  This study will test whether adding vericiguat to usual heart‑failure treatment helps adults with stable HFrEF improve right‑ventricular function and heart remodeling over 12 months.

  Recruiting at 4 sites Phase 4 University Medical Centre Ljubljana · Izola and 3 other locations · NCT07405944

• Safety of finerenone in adults with chronic heart failure (LVEF ≥ 40%) in South Korea

  This project will see if finerenone is safe for adults in South Korea who have chronic heart failure with a left ventricular ejection fraction of 40% or higher while they take it as usual care.

  Recruiting Bayer · Multiple Locations · NCT07379840

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.